Literature DB >> 16133124

Apoptotic signaling proteins: possible participation in the regulation of vasopressin and catecholamines biosynthesis in the hypothalamus.

Elena V Chernigovskaya1, Andrey G Taranukhin, Margarita V Glazova, Liubov A Yamova, Lev M Fedorov.   

Abstract

The role of apoptotic signaling proteins for long-lived neurons in the mature brain is poorly understood. Recently, we have shown that water deprivation leads to the activation of vasopressin (VP) secretion and expression of Bcl-2 and caspase-9 apototic proteins in the hypothalamus of the rat brain. In the present work, we continued to study a possible relationship between the functional activity of neurosecretory cells of the hypothalamus and apoptosis related proteins. We found that water deprivation leads to simultaneous activation of synthesis of VP and p53 and Bcl-2 apoptotic proteins in the mouse brain. To study a possible effect of apoptotic proteins on the functional state of hypothalamic neurons, the VP and tyrosine hydroxylase (TH) synthesis were analyzed in p53, p21(Waf1/Cip1) and Bcl-2 deficient mice. Loss of p53 and Bcl-2 significantly reduced VP synthesis in paraventricular and supraoptic nuclei and TH expression in arcuat, periventricular and zona incerta nuclei of the hypothalamus. Surprisingly, in contrast with the loss of p53, the inactivation of p21(Waf1/Cip1) up-regulates the expression of VP and TH. These data indicate that p53, p21(Waf1/Cip1) and Bcl-2 proteins, besides affecting cell cycle, tumor suppression and apoptosis, may act as modulators of neurosecretory activity of hypothalamic neurons; however, this problem remains to be determined more detailed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133124     DOI: 10.1007/s00418-005-0016-x

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  38 in total

1.  Single cell reverse transcription-polymerase chain reaction analysis of rat supraoptic magnocellular neurons: neuropeptide phenotypes and high voltage-gated calcium channel subtypes.

Authors:  E Glasgow; K Kusano; H Chin; E Mezey; W S Young; H Gainer
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

Review 2.  Factors intrinsic to the neuron can induce and maintain its ability to promote axonal outgrowth: a role for BCL2?

Authors:  K Holm; O Isacson
Journal:  Trends Neurosci       Date:  1999-06       Impact factor: 13.837

3.  Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.

Authors:  C Perez-Sanchez; V S Budhram-Mahadeo; D S Latchman
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

4.  Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice.

Authors:  R Amson; J M Lassalle; H Halley; S Prieur; F Lethrosne; J P Roperch; D Israeli; M C Gendron; C Duyckaerts; F Checler; J Dausset; D Cohen; M Oren; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 5.  Bcl-2 and Ca(2+)-mediated mitochondrial dysfunction in neural cell death.

Authors:  A N Murphy; G Fiskum
Journal:  Biochem Soc Symp       Date:  1999

6.  Differential changes of bax, caspase-3 and p21 mRNA expression after transient focal brain ischemia in the rat.

Authors:  R Schmidt-Kastner; J Truettner; W Zhao; L Belayev; C Krieger; R Busto; M D Ginsberg
Journal:  Brain Res Mol Brain Res       Date:  2000-06-23

7.  Tissue-specific p53 expression in the nervous system.

Authors:  Y Tendler; G Weisinger; R Coleman; E Diamond; S Lischinsky; H Kerner; V Rotter; O Zinder
Journal:  Brain Res Mol Brain Res       Date:  1999-09-08

8.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

Authors:  T Miyashita; S Krajewski; M Krajewska; H G Wang; H K Lin; D A Liebermann; B Hoffman; J C Reed
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

9.  Tumor spectrum analysis in p53-mutant mice.

Authors:  T Jacks; L Remington; B O Williams; E M Schmitt; S Halachmi; R T Bronson; R A Weinberg
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

10.  A subset of p53-deficient embryos exhibit exencephaly.

Authors:  V P Sah; L D Attardi; G J Mulligan; B O Williams; R T Bronson; T Jacks
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

View more
  6 in total

Review 1.  Recent progress in histochemistry and cell biology: the state of the art 2005.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2005-11-11       Impact factor: 4.304

Review 2.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

3.  Sexual differentiation of vasopressin innervation of the brain: cell death versus phenotypic differentiation.

Authors:  Geert J de Vries; Michelle Jardon; Mohammed Reza; Greta J Rosen; Eleanor Immerman; Nancy G Forger
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

4.  Involvement of transcription factor p53 and leptin in control of porcine ovarian granulosa cell functions.

Authors:  A V Sirotkin; A Benčo; A Tandlmajerová; D Vašíček
Journal:  Cell Prolif       Date:  2011-12-07       Impact factor: 6.831

5.  Role of neuronal nitric oxide in the regulation of vasopressin expression and release in response to inhibition of catecholamine synthesis and dehydration.

Authors:  Liubov Yamova; Dmitriy Atochin; Margarita Glazova; Elena Chernigovskaya; Paul Huang
Journal:  Neurosci Lett       Date:  2007-09-11       Impact factor: 3.046

Review 6.  Experimental Models of Maternal Obesity and Neuroendocrine Programming of Metabolic Disorders in Offspring.

Authors:  Clare M Reynolds; Stephanie A Segovia; Mark H Vickers
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-25       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.